GR3021428T3 - Pyridobenzodiazepines, dipyrido [3,2-b:2',3'-e] [1,4]diazepines and their use in the prevention or treatment of HIV infection - Google Patents

Pyridobenzodiazepines, dipyrido [3,2-b:2',3'-e] [1,4]diazepines and their use in the prevention or treatment of HIV infection

Info

Publication number
GR3021428T3
GR3021428T3 GR960402800T GR960402800T GR3021428T3 GR 3021428 T3 GR3021428 T3 GR 3021428T3 GR 960402800 T GR960402800 T GR 960402800T GR 960402800 T GR960402800 T GR 960402800T GR 3021428 T3 GR3021428 T3 GR 3021428T3
Authority
GR
Greece
Prior art keywords
pyridobenzodiazepines
dipyrido
diazepines
prevention
treatment
Prior art date
Application number
GR960402800T
Other languages
English (en)
Inventor
Karl D Hargrave
Ernest Cullen
John R Proudfoot
Karl G Grozinger
Kollol Pal
Julian Adams
Original Assignee
Boehringer Ingelheim Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Ingelheim Pharma filed Critical Boehringer Ingelheim Pharma
Publication of GR3021428T3 publication Critical patent/GR3021428T3/el

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/12Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains three hetero rings
    • C07D471/14Ortho-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D495/00Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/12Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains three hetero rings
    • C07D495/14Ortho-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/547Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/6561Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing systems of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring or ring system, with or without other non-condensed hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Virology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Biochemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Molecular Biology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
GR960402800T 1991-02-07 1996-10-23 Pyridobenzodiazepines, dipyrido [3,2-b:2',3'-e] [1,4]diazepines and their use in the prevention or treatment of HIV infection GR3021428T3 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US65214791A 1991-02-07 1991-02-07
US65215791A 1991-02-07 1991-02-07
US65214691A 1991-02-07 1991-02-07

Publications (1)

Publication Number Publication Date
GR3021428T3 true GR3021428T3 (en) 1997-01-31

Family

ID=27417873

Family Applications (1)

Application Number Title Priority Date Filing Date
GR960402800T GR3021428T3 (en) 1991-02-07 1996-10-23 Pyridobenzodiazepines, dipyrido [3,2-b:2',3'-e] [1,4]diazepines and their use in the prevention or treatment of HIV infection

Country Status (7)

Country Link
EP (1) EP0498290B1 (el)
JP (1) JPH06122683A (el)
AT (1) ATE143018T1 (el)
CA (1) CA2060687A1 (el)
DE (1) DE69213777T2 (el)
DK (1) DK0498290T3 (el)
GR (1) GR3021428T3 (el)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6177435B1 (en) 1992-05-13 2001-01-23 Glaxo Wellcome Inc. Therapeutic combinations
US5897858A (en) 1994-02-03 1999-04-27 Schering-Plough Healthcare Products, Inc. Nasal spray compositions exhibiting increased retention in the nasal cavity
DE69502587T2 (de) * 1994-02-18 1998-11-26 Boehringer Ingelheim Pharma 2-heteroaryl-5,11-dihydro-6h-dipyrido[3,2-b:2',3'-e] [1,4]diazepine und ihre verwendung zur vorbeugung und behandlung von hiv-infektion
US5747488A (en) * 1996-01-30 1998-05-05 Boehringer Ingelheim Pharmaceuticals, Inc. 2-aryl-5,11-dihydro-6H-dipyrido 3,2-B:2',3'-E! 1, 4!diazepines and their use in the treatment of HIV infection
US6106179A (en) * 1998-12-28 2000-08-22 Kuo; Chen-Hui Dual color lipstick in a single case
WO2008099021A1 (en) * 2007-02-16 2008-08-21 Tibotec Pharmaceuticals Ltd. Dibenzodiazepinones useful as hepatitis c virus inhibitors
CU20090172A7 (es) 2009-10-09 2011-10-05 Ct De Investigación Y Desarrollo De Medicamentos Sistemas tricíclicos y tetracíclicos con actividad sobre el sistema nervioso central y vascular

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0393604B1 (en) * 1989-04-20 1997-12-29 Boehringer Ingelheim Pharmaceuticals Inc. 6,11-Dihydro-5H-pyrido(2,3-b)(1,5,)benzodiazepin-5-ones and thiones and their use in the prevention or treatment of AIDS
ATE103918T1 (de) * 1989-06-28 1994-04-15 Boehringer Ingelheim Pharma 5,11-dihydro-6h-dipyrido(3,2-b:2',3'e>(1,4>diazepin-6-one und -thione und ihre verwendung bei der aids-vorbeugung oder behandlung.

Also Published As

Publication number Publication date
DE69213777D1 (de) 1996-10-24
EP0498290A1 (en) 1992-08-12
DK0498290T3 (el) 1997-02-10
ATE143018T1 (de) 1996-10-15
DE69213777T2 (de) 1997-03-13
CA2060687A1 (en) 1992-08-08
JPH06122683A (ja) 1994-05-06
EP0498290B1 (en) 1996-09-18

Similar Documents

Publication Publication Date Title
GR3030100T3 (en) 5,11-Dihydro-6H-dipyrido[3,2-b:2',3'-e] [1,4]diazepines and their use in the prevention or treatment of HIV infection
ATE235495T1 (de) 8-arylalkyl- und 8-arylheteroalkyl-5, 11-dihydro- 6h-dipyrido-(3,2-b:2', 3'-e)(1,4)diazepine und ihre verwendung zur vorbeugung oder behandlung von hiv-infektion
OA09741A (en) "novel 5,11-dihydro-6H-dipzrido /3,2-b: 2',3'-e/ /1,4/ diazepin-6-ones and thiones and their use in the prevention or treatment of aids".
GR3021428T3 (en) Pyridobenzodiazepines, dipyrido [3,2-b:2',3'-e] [1,4]diazepines and their use in the prevention or treatment of HIV infection
DK0543000T3 (da) Fremgangsmåde til fremstilling af 3-amino-2-chlor-4-alkylpyridiner
ES2058656T3 (es) 5,11-dihidro-6h-dipirido(3,2-b:2',3'-e)(1,4)diazepin-6-onas y su uso en la prevencion o tratamiento del sida.
CA2014885A1 (en) 6,11-dihydro-5h-pyrido[2,3-b][1,5]benzodiazepin-5-ones and thiones and their use in the prevention or treatment of aids
PL316006A1 (en) 2-heteroaryl-5,11-dihydro-6h-dipyrido[3,2-b',3'-e][1,4] diazepines and their application in preventing and treating hiv infections
MX9202769A (es) Metodo para la preparacion de 3-amino-2-cloro-4-alquilpiridinas.
GR3015469T3 (en) 5,11-dihydro-6H-pyrido[2,3,-b][1,4]benzodiazepin-6-ones and -thiones and their use in the prevention or treatment of AIDS.
GR3018683T3 (en) Pyrido [2,3-b][1,5]benzoxazepin (and thiazepin)-5(6H)-ones and -thiones and their use in the prevention or treatment of HIV infection
ZA909246B (en) 5,11-dihydro-6h-dipyrido(3,2-b:2',3'-e)(1,4)diazepines and their use in the prevention or treatment of hiv infection
OA09307A (en) "Pyrido /2, 3-b/ /1, 5/ benzoxazepin (and thiazepin) -5(6H) -ones and-thiones and their use in the prevention or treatment of HIV infection".
EP0415304A3 (en) Dipyrido(3,2-b:2',3'-e)(1,4)oxazepin (and thiazepin)-6(5h)-ones and -thiones and their use in the prevention or treatment of aids
ZA951318B (en) 2-heteroaryl-5,11-dihydro-6H-dipyrido[3,2-b:2',3'-e][1,4] diazepines and their use in the prevention or treatment of HIV infection
PH31562A (en) Pyrido (2,3-B) (1,5) benzoxazepin (and thiazepin)-5(6H)-ones and thiones and their use on the treatment of hiv infection.
CA2187146A1 (en) 8-arylalkyl- and 8-arylheteroalkyl-5,11-dihydro-6h-dipyrido[3,2-b:2',3'-e]-[1,4]- diazepines and their use in the prevention or treatment of hiv infection